Skip to main content

Table 4 Provisional Classification Criteria for Refractory SJIA

From: Proceedings from the 2nd Next Gen Therapies for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome symposium held on October 3-4, 2019

Failure to respond to IL-1 AND IL-6 blocking biologics (failure = inability to resolve arthritis, systemic symptoms, or liver dysfunction, or being steroid dependent)

OR

≥2 episodes of MAS in a 2 year period

OR

Development of SJIA-LD